Home > Boards > US OTC > Miscellaneous >

Therapeutic Solutions International, Inc. (TSOI)

Add TSOI Price Alert      Hide Sticky   Hide Intro
Moderator: centsability4me
Search This Board: 
Last Post: 3/21/2018 7:55:30 PM - Followers: 83 - Board type: Free - Posts Today: 0

Therapeutic Solutions International, Inc.

is a public company  focused on immune
modulation for the treatment of several specific diseases.

Corporate website :
E-commerce site :
Additional information :

Nutraceutical Division – TSI has been producing very high quality nutraceuticals. Its flagship product, Projuvenol®, is a Patented (No. 9,682,047) proprietary mixture containing pterostilbene – one of the most potent antioxidants known.

Subsidiaries : 

SandBox Dental Labs, Inc. – is a majority owned subsidiary of TSI consisting of a dental laboratory to manufacture and fill prescriptions from dentists who will use our proprietary Sleep Appliance to treat their patients with mild to moderate obstructive sleep apnea.

Emvolio, Inc. – is a majority owned subsidiary of TSI where the intellectual property surrounding immune-oncology is housed.  The Company is developing products that can be used together to attack cancer at different levels, as well as to be used alone or in combination with existing therapies.

OmniBiome, Inc. – is a majority owned subsidiary of TSI where the intellectual property surrounding probiotics is housed. Current programs focus on the use of probiotics to prevent pre-term labor and on using probiotics to reverse periodontal disease.

Share Structure :
AS - 990 M (as of 7/7/17)
OS - 806,501,000 (as of 11/15/17)
Float - 46,317,028 (as of 7/7/17)

Patents :
Patent Filed  Patent Name Press Release
 07-08-15  Augmentation of Oncology Immunotherapies by Pterostilbene Containing Compositions  07-09-15
 07-21-15  Prevention of Pregnancy Complications by Probiotic Administration 07-22-15
 09-02-15  Preventative Methods and Therapeutic or Pharmaceutical Compositions for the Treatment or Prevention of Pregnancy Complications 09-08-15
 09-15-15  Diagnostic Methods For The Assessment Of Pregnancy Complications 09-21-15
 09-25-15  A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth 09-29-15
11-20-15  Exosome Mediated Innate and Adaptive Immune Stimulation for Treatment of Cancer 11-23-15
04-27-16  Augmentation Of Stem Cell Activity Using Ppterostilbene And Compositions Containing Pterostilbene  04-28-16
 03-29-17  Stimulation of Immunity to Tumor Stem Cell Specific Proteins by Peptide Immunization 04-10-17
 03-29-17  Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants  05-09-17
 03-29-17  Activated Leukocyte Extract for Repair of Innate Immunity in Cancer Patients  05-16-17
 03-29-17  Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof 05-22-17
 03-29-17  Methods of Re-Activating Dormant Memory Cells with Anticancer Activity 06-05-17
 10-08-17 Synergistic Inhibition of Glioma Using Pterostilbene and Analogues Thereof 10-16-17

Management and Board of Directors


Timothy G. Dixon – President, CEO, & Chairman

Mr. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon also serves as President and Chairman of OmniBiome, Inc.,and President. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011. Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies.

Gerry B. Berg – Vice President, CFO, Director

Gerry B. Berg has served as our Vice-President and Chief Financial Officer since April 20, 2011.  Mr. Berg became a director of the Company on August 24, 2012.  Mr. Berg has over 30 years of senior management experience working with private and public companies.  From May 2010 to March 2011, Mr. Berg served as President and Chairman of the Board of Directors of Friendly Auto Dealers, Inc. and also served in a consulting capacity from March 2009 to May 2010.

Mr. Berg holds a Bachelors of Science in Accounting from Walsh College where he graduated Cum Laude.  Mr. Berg became a Certified Public Accountant in the State of Michigan in 1979 and in the State of California in 1984.  Mr. Berg does not currently practice as a Certified Public Accountant.

Thomas E.Ichim, Ph.D – Director

Dr. Ichim was appointed to the Board of Directors on January 22, 2016.  Dr. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded/co-founded several companies including Batu Biologics, Inc., Medvax Pharma Corp, ToleroTech Inc, bioRASI, and OncoMune LLC. To date he has published 99 peer-reviewed articles and is co-editor of the textbooks “RNA Interference: From Bench to Clinical Translation” and “Immuno-Oncology Text Book.”

Dr. Ichim is an ad-hoc editor and sits on several editorial boards. Dr Ichim is inventor on over 50 patents and patent applications. Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. Dr. Ichim spent over 7 years as the President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing, IND filing, and up through Phase II clinical trials with the FDA. Dr. Ichim has extensive experience in product development, regulatory filings, and business development.

Dr. Ichim has a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada, a MSc in Microbiology and Immunology a University of Western Ontario, London, Ontario, Canada and a Ph.D in Immunology from the University of Sciences Arts and Technology, Olveston Monserrat.

Hong Ma, MD, Ph.D., M.B.A. – Chief Scientific Officer

Dr. Ma has an extensive history in academic and translational research. Subsequent to completing her medical degree, she performed basic research in the area of molecular biology of endothelial-associated pathways in her doctorate and postdoctoral studies. She has been critical in establishing numerous ventures and collaborations in the area of biosciences. Dr. Ma has over 20 peer-reviewed publications and has worked with prestigious institutions in the USA, China, and Japan. She received her M.D. from Dalian Medical University, her Ph.D in Cardiovascular Pharmacology at Asahikawa Medical College, and has also earned her MBA at the Rady School of Management at the University of California San Diego.

Contact :
E - mail :
Address : 
4093 Oceanside Blvd.
Suite B
Oceanside , CA
Phone :
(760) 295 - 7208

Disclaimer : All of the information presented in the IBOX , Stickies , or posts on this board ,  is based on individual opinions , and is not to be considered as a recommendation to buy , sell , or hold this stock .

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TSOI News: Therapeutic Solutions International Develops "NanoStilbene" Nanoparticle Formulation of Pterostilbene 03/05/2018 09:00:00 AM
TSOI News: Therapeutic Solutions International, Inc. Recruits Top Doctor of San Diego to Scientific Advisory Board 02/27/2018 09:00:00 AM
TSOI News: Quarterly Report (10-q) 11/16/2017 01:38:02 PM
TSOI News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/14/2017 01:51:33 PM
TSOI News: Therapeutic Solutions International, Inc. strengthens Scientific Advisory Board with the Appointment of Pablo A. Guzman, MD. 10/17/2017 08:20:16 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#5889   nothing ever happens i dont get it, been kstock 03/21/18 07:55:30 PM
#5888   frustrating... corvatsch 03/21/18 05:18:45 PM
#5887   TSI patent info update : centsability4me 03/18/18 06:59:38 AM
#5886   Thank you Cents rakp 03/12/18 01:42:26 PM
#5885   TSI centsability4me 03/12/18 12:31:45 PM
#5884   Agreed centsability4me 03/12/18 09:04:46 AM
#5883   I get the feeling this company is slowly rakp 03/11/18 05:16:26 AM
#5882   a new therapy centsability4me 03/09/18 07:40:55 AM
#5881   very well cents. corvatsch 03/08/18 02:20:12 PM
#5880   TSI NanoStilbene centsability4me 03/08/18 12:55:43 PM
#5879   Nanoemulsion DD centsability4me 03/08/18 11:18:05 AM
#5878   Nanoparticle centsability4me 03/08/18 10:59:20 AM
#5877   DD on Ptero centsability4me 03/05/18 01:12:53 PM
#5876   NEWS 3/5/18 centsability4me 03/05/18 09:05:29 AM
#5875   2.38 M vol. centsability4me 03/02/18 07:05:49 PM
#5874   we hope well !!! corvatsch 02/27/18 05:21:06 PM
#5873   volume now 1.8 M centsability4me 02/27/18 04:32:08 PM
#5872   Another link to today's PR centsability4me 02/27/18 04:12:51 PM
#5871   Dr. James Veltmeyer's Bio centsability4me 02/27/18 09:14:07 AM
#5870   NEWS 2/27/18 centsability4me 02/27/18 09:04:41 AM
#5869   corvatch centsability4me 02/19/18 12:29:00 PM
#5868   TSOI Market Cap corvatsch 02/17/18 02:32:34 PM
#5867   TSI is centsability4me 02/17/18 12:43:32 PM
#5866   another wonderful centsability4me 02/16/18 02:09:42 PM
#5865   13-02-2018. vol. 5.575.000... !!! corvatsch 02/13/18 04:25:26 PM
#5864   Ptero centsability4me 02/04/18 01:08:59 PM
#5863   TSI centsability4me 02/04/18 12:43:38 PM
#5862   vol. 3.750.000 !!! corvatsch 02/01/18 05:45:31 PM
#5861   today vol. 2.062.000.... corvatsch 02/01/18 03:57:45 PM
#5860   kstock, not recently . e-mailing them gets responses . centsability4me 01/26/18 09:40:31 PM
#5859   cents have you had any contact with any kstock 01/26/18 04:54:41 PM
#5858   skin stilbene centsability4me 01/26/18 03:35:35 PM
#5857   the link said: centsability4me 01/26/18 03:10:54 PM
#5856   Stilbene centsability4me 01/26/18 02:20:25 PM
#5855   In addition to centsability4me 01/16/18 07:17:17 AM
#5854   TSI has entered into centsability4me 01/15/18 02:53:00 PM
#5853   kirk5 , centsability4me 01/15/18 10:11:38 AM
#5852   cents do you know if their is any kstock 01/14/18 10:28:23 AM
#5851   10:01 - 3 gen 2018. corvatsch 01/07/18 05:28:58 PM
#5850   THANKS CENTS!!! corvatsch 01/05/18 09:17:16 AM
#5849   TSOI update centsability4me 01/04/18 11:11:13 AM
#5848   TSOI centsability4me 12/26/17 12:33:08 PM
#5847   That’s for sure. This is like watching paint Bob842 12/13/17 03:02:30 PM
#5846   no volume, no party !!! corvatsch 12/13/17 01:50:01 PM
#5845   with all of these centsability4me 12/12/17 11:57:34 AM
#5844   MemoryMune centsability4me 12/03/17 08:08:00 AM
#5843   More on MemoryMune : centsability4me 12/03/17 07:58:16 AM
#5842   Thanks CENTS. corvatsch 12/01/17 02:35:24 PM
#5841   DISCUSSION We have established that pterostilbene can potentiate the centsability4me 12/01/17 01:41:24 PM
#5840   Re: pterostilbene centsability4me 12/01/17 12:57:57 PM